Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
06 2020
Historique:
received: 21 11 2019
revised: 09 03 2020
accepted: 10 03 2020
pubmed: 23 3 2020
medline: 29 8 2020
entrez: 23 3 2020
Statut: ppublish

Résumé

Incidental findings such as meningioma are becoming increasingly prevalent. There is no consensus on the optimal management of these patients. The aim of this study was to examine the outcomes of patients diagnosed with an incidental meningioma who were treated with surgery or radiotherapy. Single-center retrospective cohort study of adult patients diagnosed with an incidental intracranial meningioma (2007-2015). Outcomes recorded were postintervention morbidity, histopathologic diagnosis, and treatment response. Out of 441 patients, 44 underwent treatment. Median age at intervention was 56.1 years (interquartile range [IQR], 49.6-66.5); patients included 35 women and 9 men. The main indication for imaging was headache (25.9%). Median meningioma volume was 4.55 cm The morbidity after treatment of incidental intracranial meningioma is not negligible. Considering most operated tumors are WHO grade 1, treatment should be reserved for those manifesting symptoms or demonstrating substantial growth on radiologic surveillance.

Sections du résumé

BACKGROUND
Incidental findings such as meningioma are becoming increasingly prevalent. There is no consensus on the optimal management of these patients. The aim of this study was to examine the outcomes of patients diagnosed with an incidental meningioma who were treated with surgery or radiotherapy.
METHODS
Single-center retrospective cohort study of adult patients diagnosed with an incidental intracranial meningioma (2007-2015). Outcomes recorded were postintervention morbidity, histopathologic diagnosis, and treatment response.
RESULTS
Out of 441 patients, 44 underwent treatment. Median age at intervention was 56.1 years (interquartile range [IQR], 49.6-66.5); patients included 35 women and 9 men. The main indication for imaging was headache (25.9%). Median meningioma volume was 4.55 cm
CONCLUSIONS
The morbidity after treatment of incidental intracranial meningioma is not negligible. Considering most operated tumors are WHO grade 1, treatment should be reserved for those manifesting symptoms or demonstrating substantial growth on radiologic surveillance.

Identifiants

pubmed: 32200011
pii: S1878-8750(20)30529-5
doi: 10.1016/j.wneu.2020.03.060
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e725-e735

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Abdurrahman I Islim (AI)

Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; School of Medicine, University of Liverpool, Liverpool, United Kingdom; Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom. Electronic address: a.islim@liv.ac.uk.

Midhun Mohan (M)

School of Medicine, University of Liverpool, Liverpool, United Kingdom; Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Richard D C Moon (RDC)

School of Medicine, University of Liverpool, Liverpool, United Kingdom; Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Nitika Rathi (N)

Department of Neuropathology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Ruwanthi Kolamunnage-Dona (R)

Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

Anna Crofton (A)

Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Brian J Haylock (BJ)

Department of Clinical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom.

Samantha J Mills (SJ)

Department of Neuroradiology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Andrew R Brodbelt (AR)

Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Michael D Jenkinson (MD)

Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH